The PCN pharmacy workforce is “moving away from” structured medication review (SMR) delivery despite “strong evidence” of their clinical and economic impact, the Royal Pharmaceutical Society (RPS) warned in a policy statement last month (July 23).
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?